Quest Diagnostics (DGX) Net Cash Flow (2009 - 2026)

Quest Diagnostics has disclosed Net Cash Flow across 18 years of filings, most recently posting -$26.0 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$26.0 million, up 92.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $203.0 million (up 172.5% YoY), and the FY2025 annual result was -$133.0 million, down 2.31% from the prior year.
• Net Cash Flow came in at -$26.0 million for Q1 2026 at Quest Diagnostics, down from -$13.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $543.0 million in Q4 2023 to a low of -$385.0 million in Q4 2022.
• The 5-year median for Net Cash Flow is -$49.0 million (2023), against an average of -$27.9 million.
• Across the five-year window, Net Cash Flow tumbled 322.22% in 2022 and jumped 2800.0% in 2024, its largest moves.
• Quest Diagnostics' Net Cash Flow stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then plunged by 138.31% to -$208.0 million in 2024, then jumped by 93.75% to -$13.0 million in 2025, then sank by 100.0% to -$26.0 million in 2026.
• The last three Net Cash Flow figures came in at -$26.0 million (Q1 2026), -$13.0 million (Q4 2025), and $115.0 million (Q3 2025), per Business Quant data.